Results 1 to 10 of about 98,536 (314)

Surface-Degradable Drug-Eluting Stent with Anticoagulation, Antiproliferation, and Endothelialization Functions

Biomolecules, 2019
Drug-eluting stents (DES) have been widely applied for saving the life of patients with coronary artery diseases (CADs). However, conventional polymers such as polylactic acid (PLA) and poly (lactic-co-glycolic acid) (PLGA), which are widely applied for ...
Ruixia Hou, Leigang Wu, Jin Wang, Zhilu Yang, Qiufen Tu, Xingcai Zhang, Nan Huang   +6 more
doaj   +2 more sources

Paclitaxel Drug-eluting Tracheal Stent Could Reduce Granulation Tissue Formation in a Canine Model

Chinese Medical Journal, 2016
Background: Currently available silicone and metallic stents for tracheal stenosis are associated with many problems. Granulation proliferation is one of the main complications.
Ting Wang, Jie Zhang, Juan Wang, Ying-Hua Pei, Xiao-Jian Qiu, Yu-Ling Wang   +5 more
doaj   +2 more sources

A drug-free cardiovascular stent functionalized with tailored collagen supports in-situ healing of vascular tissues

Nature Communications
Drug-eluting stent implantation suppresses the excessive proliferation of smooth muscle cells to reduce in-stent restenosis. However, the efficacy of drug-eluting stents remains limited due to delayed reendothelialization, impaired intimal remodeling ...
Haoshuang Wu, Li Yang, Rifang Luo, Li Li, Tiantian Zheng, Kaiyang Huang, Yumei Qin, Xia Yang, Xingdong Zhang, Yunbing Wang   +9 more
doaj   +2 more sources

Drug-eluting stents [PDF]

Canadian Medical Association Journal, 2007
In their recent systematic review, Suzanne Ligthart and associates compared analyses of the cost-effectiveness of drug-eluting stents.[1][1] They found that in most studies in which an incremental cost-effectiveness ratio greater than $50 000 per quality-adjusted life-year was calculated the ...
Tangri N, Falcone El
  +16 more sources

Drug eluting stents [PDF]

BMJ, 2006
Last week an expert panel of the US Food and Drug Administration (FDA) recommended that the FDA should issue warnings to doctors and patients about drug eluting coronary stents. The safety of such stents is unclear except in low risk patients. Furthermore, patients with drug eluting stents should take antiplatelet therapy for at least one year after ...
Gershlick, AH, Richardson, G
  +13 more sources

Comparison of Drug-Eluting Stent With Bare-Metal Stent in Patients With Symptomatic High-grade Intracranial Atherosclerotic Stenosis: A Randomized Clinical Trial.

JAMA Neurology, 2022
Importance In-stent restenosis (ISR) is the primary reason for stroke recurrence after intracranial stenting in patients who were treated with a standard bare-metal stent (BMS).
Baixue Jia, Xuelei Zhang, N. Ma, D. Mo, F. Gao, Xuan Sun, Ligang Song, Lian Liu, Yiming Deng, Xiaotong Xu, Yong Zhang, Zengpin Liu, S. Guan, Fan Zhang, Bing Li, Hongbo Zheng, Xinfeng Liu, Yajie Liu, Kangning Chen, Jie Shuai, J. Wan, Jun Wang, Xiang-fei Shi, Tianxiao Li, Binge Chang, D. Liebeskind, Wengui Yu, Z. Miao   +27 more
semanticscholar   +1 more source

Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation

Circulation. Cardiovascular Quality and Outcomes, 2021
Supplemental Digital Content is available in the text. Background: There is increasing evidence that use of intravascular ultrasound (IVUS) guidance during percutaneous coronary intervention (PCI) is associated with improved clinical outcomes compared ...
Jennifer Y. Zhou, D. Liew, S. Duffy, J. Shaw, A. Walton, W. Chan, R. Gerber, D. Stub   +7 more
semanticscholar   +1 more source

Aneurysmal degeneration of fluoropolymer-coated paclitaxel-eluting stent in the superficial femoral artery: a rising concern

CVIR Endovascular, 2021
Background Although several clinical reports demonstrated a durable patency rate after a novel fluoropolymer-coated paclitaxel-eluting stent (Eluvia; Boston Scientific, Marlborough, MA, USA) placement, aneurysmal degeneration after drug-eluting stent ...
Takuya Tsujimura, Osamu Iida, Mitsutoshi Asai, Masaharu Masuda, Shin Okamoto, Takayuki Ishihara, Kiyonori Nanto, Takashi Kanda, Yasuhiro Matsuda, Yosuke Hata, Hiroyuki Uematsu, Taku Toyoshima, Naoko Higashino, Toshiaki Mano   +13 more
doaj   +1 more source

Impact of Coronary Calcification on Clinical Outcomes After Implantation of Newer‐Generation Drug‐Eluting Stents

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Percutaneous coronary intervention of calcified lesions was associated with worse outcomes in the era of bare‐metal and first‐generation drug‐eluting stents. Data on percutaneous coronary intervention of calcified lesions with newer‐generation
Rayyan Hemetsberger, Mohammad Abdelghani, Ralph Toelg, Nader Mankerious, Abdelhakim Allali, Hector M. Garcia‐Garcia, Stephan Windecker, Thierry Lefèvre, Shigeru Saito, Ton Slagboom, David Kandzari, Jacques Koolen, Ron Waksman, Gert Richardt   +13 more
doaj   +1 more source

Drug-eluting stent thrombosis [PDF]

Therapeutic Advances in Cardiovascular Disease, 2009
Stent thrombosis is a rare complication following stent implantation; if it occurs, however, it is associated with a high morbidity and mortality. Despite reduced rates of restenosis, drug-eluting stents (DES) have not reduced the incidence of stent thrombosis as compared with bare-metal stents (BMS).
Stähli, B E, Camici, G G, Tanner, F C
openaire   +3 more sources